Fig. 5From: Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trialsa Forest plot, and b Trial Sequential Analysis of effects of SGLT2i on cardiovascular mortality in 23 studiesBack to article page